Unknown

Dataset Information

Visual Field Endpoints for Neuroprotective Trials: A Case for AI-Driven Patient Enrichment.


ABSTRACT:

Purpose

To evaluate whether an artificial intelligence (AI) model can better select candidates that would demonstrate visual field (VF) progression, in order to shorten the duration or the number of patients needed for a clinical trial.

Design

Retrospective cohort study.

Methods

7428 eyes of 3871 patients from the University of Washington Department of Ophthalmology VF Dataset were included. Progression was defined as at least 5 locations with >7 dB of change compared with baseline on 2 consecutive tests. Progression for all patients, a subgroup of the fastest progressing based on survival curves, and patients selected based on an elastic net Cox regression model were compared. The model was trained on pointwise threshold deviation values of the first VF, age, gender,

SUBMITTER: Chen A 

PROVIDER: S-EPMC9837863 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature